Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001763494-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 2, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
180,000
Total Value
$2,783,439.18
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Apr 1, 2026 | Exercise/Conversion | 60,000 | $15.46 | $927,600.00 | 492,886 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 1, 2026 | Sale | 34,902 | $30.55 | $1,066,256.10 | 457,984 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 1, 2026 | Sale | 25,098 | $31.46 | $789,583.08 | 432,886 | Direct | โ | View Details | |
Director | Employee stock option (right to buy) | Derivative | Apr 1, 2026 | Exercise/Conversion | 60,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details |